Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 24, 2024 08:00 ET
Canadian Large Cap Leaders Split Corp. Receives Approval for Normal Course Issuer Bid
Ninepoint Partners LP (“Ninepoint”), on behalf of Canadian Large Cap Leaders Split Corp. (the “Company”) (TSX: NPS/NPS.PR.A), announced today that the Toronto Stock Exchange (the “TSX”) has accepted its notice of intention to make a normal course...
May 24, 2024 08:00 ET
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual Me
CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced final results from the...
May 24, 2024 08:00 ET
Cullinan Therapeutics to Participate in Fireside Chat at TD Cowen 5th Annual Oncology Innovation Summit
Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced that Nadim Ahmed, Chief Executive Officer and Jeffrey Jones, MD, MBA, Chief Medical Officer, will...
May 24, 2024 08:00 ET
Fostering Social Connections in the Virtual Workplace
In the wake of the seismic shift towards hybrid and remote work models, some of the top concerns surfacing for Canadian organizations are those related to social connectedness, according to new research from The Conference Board of Canada. “Given...
May 24, 2024 08:00 ET
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
Genelux Corporation (Genelux) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten offering of 6,875,000 shares of its common stock and accompanying warrants to purchase 6,875,000 shares of...
May 24, 2024 08:00 ET
IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024
IN8bio, Inc. (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced multiple presentations at the International Society for Cell & Gene Therapy 2024, to be held May 28th to June...
May 24, 2024 08:00 ET
Monopar Announces CFO Succession
Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that after a career spanning more than 35 years, Monopar’s Chief Financial...
May 24, 2024 08:00 ET
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sonder Holdings Inc. (“Sonder” or “the Company”) (NASDAQ: SOND) and certain of its...
May 24, 2024 08:00 ET
Weebit Nano and Efabless collaborate to enable easy, affordable prototyping of innovative SoC designs
Weebit Nano Limited (ASX:WBT), a leading developer and licensor of advanced memory technologies for the global semiconductor industry, and Efabless Corporation, the creator platform for chips, announce their collaboration to enable fast and easy...
May 24, 2024 07:30 ET
BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting
BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced today that 12 oral and moderated poster presentations will be shared at the 2024...
May 24, 2024 07:30 ET
BULGOLD Announces Filing of First Quarter Financial Results for Three Months Ended March 31, 2024
BULGOLD Inc. (TSXV: ZLTO) (the “Company” or “BULGOLD”) is pleased to announce that it has filed its unaudited condensed interim financial statements and MD&A for the first quarter ended March 31, 2024. During the three months ended March 31, 2024,...
May 24, 2024 07:30 ET
Gulf & Pacific Equities Corp. reports on First Quarter Results with Revenue of $1,087,886
Gulf & Pacific Equities Corp. (TSX-V: GUF) an established company focused on the acquisition, management and development of anchored shopping centres in Western Canada, reports a 11.5% increase in revenues to $1,087,886 in the quarter ended March...
May 24, 2024 07:30 ET
Ollie’s Bargain Outlet Winning Bidder in Bankruptcy Auction to Acquire Eleven Former 99 Cents Only Stores
Ollie’s Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the “Company”) today announced that at the conclusion of a final sale hearing, the United States Bankruptcy Court for the District of Delaware approved the Company’s stalking horse bid to...
May 24, 2024 07:30 ET
Pasinex Announces Anticipated Late Filing of Q1 2024 Interim Filings
Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (the “Company” or “Pasinex”), announces today that the Company is anticipating a slight delay in filing its interim financial statements and accompanying management's discussion and analysis for the...
May 24, 2024 07:26 ET
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Fourth Quarter 2023, Full Year 2023 and First Quarter 2024 Financial Results
Syntec Optics Holdings, Inc. (“Syntec Optics” or the “Company”) (Nasdaq: OPTX), a leading provider of mission-critical optics to scientific and technical instruments and defense and aerospace OEMs, reported financial and operational results for the...
May 24, 2024 07:25 ET
AGF Investments Announces Revised Final Distribution for AGF Systematic Emerging Markets Equity ETF
AGF Investments Inc. (AGF Investments) today announced a revised final distribution amount for AGF Systematic Emerging Markets Equity ETF (ticker: QEM) (the “ETF”). This is an update from the distribution previously announced on May 16, 2024....
May 24, 2024 07:25 ET
AGF Investments Announces May 2024 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure ETF
AGF Investments Inc. (AGF Investments) (TSX:AGF.B) today announced the May 2024 cash distributions for AGF Enhanced U.S. Equity Income Fund*, AGF Total Return Bond Fund* and AGF Systematic Global Infrastructure ETF, which pay monthly distributions....
May 24, 2024 07:05 ET
Laguna Treatment Center Unveils New Name and Expanded Mission with Ribbon-Cutting Ceremony
Laguna Treatment Center, a leading provider of addiction treatment services, celebrated a significant milestone on May 23 with a ribbon-cutting ceremony at its newly renamed facility. The event marked the official unveiling of the center's new name...
May 24, 2024 07:00 ET
Christopher Hix joins Brady Corporation Board of Directors
Brady Corporation (NYSE: BRC) (“Brady” or “Company”) announced that Christopher Hix will join its Board of Directors, effective May 24, 2024. Mr. Hix joins the Brady Board of Directors after a 39-year career in public companies serving a broad...
May 24, 2024 07:00 ET
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced an upcoming poster...